Biologic responses to IFN-α administration in humans

Journal of Interferon and Cytokine Research

Volumn 20, Issue 12, 2000, Pages 1039-1047

  Corssmit, E P M ^a   De Metz, J ^a   Sauerwein, H P ^a   Romijn, J A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON A; RECOMBINANT ALPHA INTERFERON A; THYROID ANTIBODY;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CANCER; CLINICAL TRIAL; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; TREATMENT INDICATION; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BLOOD COAGULATION; FIBRINOLYSIS; HUMANS; IMMUNE SYSTEM; INTERFERON-ALPHA; NEUROSECRETORY SYSTEMS;

EID: 0034534406     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000750053690     Document Type: Review

References (114)

1. Virus interference
2. Chromosomal location of a human α interferon gene family
3. Interferons, a group of multiple lymphokines
4. Chromosomal localization of human leukocyte, fibroblast and immune interferon genes by means of in situ hybridization
5. A new allele of interferon-alpha 17 gene encoding IFN-alpha17b is the major variant in human population
6. The interferons: Mechanism of action and clinical applications
7. Multiple interferon subtypes: The phenomenon and its relevance
8. Production and role of interferon in physiological conditions
9. Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells
10. Interferon binding: The first step in establishment of antiviral activity
11. Interferon receptors
12. Interferon receptors
13. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons
14. Signal transduction in the interferon system
15. The distribution of immunore-active interferon-alpha in normal human tissues
16. Circulating interferon in man after administration of exogenous leukocyte interferon
17. Inactivators of fibroblast interferon found in human serum
18. Increased interferonuria in maleate-treated rabbits
19. Age-related decline of human interferon-alpha and interferon gamma production
20. The effeCt of aging on the differentiation and proliferation potentials of cells of the immune system
21. Interferons and their actions
22. Mechanisms of the anTiviral action of interferons
23. Interferons and antiviral activity
24. Immune response in mice that lack the interferon gamma receptor
25. Interferon-induced antiviral actions and their regulation
26. Circulating interferon-α levels and hypertriglyceridemia in the acquired immune deficiency syndrome
27. Radioimmunoassay of leukocyte (alpha) interferon and its application to some clinical conditions
28. Interferon treatments: How to use an endogenous system as a therapeutic agent
29. The biology of interferon actions
30. Antitumor effects of interferon preparations in mice
31. How does interferon exert its cell growth inhibitory effect?
32. Interferons and the tumor cell
33. PKR, apoptosis and cancer
34. Why do so many cancer patients fail to respond to interferon therapy?
35. Inhibition of angiogenesis
36. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
37. Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon
38. Potentiating effect of murine-γ-containing lymphokine preparation on the antiviral and antiproliferative effects of murine interferon αlβ: Identification of the potentiating factor as murine interferon-γ itself
39. Interferons
40. Cytokine therapeutics: Lessons from interferon α
41. Effects of α-interferons on immune function
42. Neutrophils and host defense
43. Tissue destruction by neutrophils
44. Granulocyte-colony-stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon-alpha
45. Effects of interferon-alpha (IFN-α) administration on leucocytes in healthy humans
46. Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2
47. Anti-inflammatory action of corticosteroid
48. Acute effects of interferon-α administration on thyroid hormone metabolism in healthy men
49. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs
50. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor alpha and lymphotoxin) production by mitogen-stimulated peripheral mononuclear blood cells
51. Interferon-alpha prevents endotoxin-induced mortality in mice
52. Cytokine regulation of human monocyte interleukin- 1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumor necrosis factor-alpha, IL-2, and IL-1 and inhibition by IFN alpha
53. The effects of various cytokines on interleukin-6 and interferon-α synthesis in human peripheral blood mononuclear cells
54. Type I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stroma cells
55. Effects of interferon-alpha on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells
56. + T cells and monocytes
57. Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells
58. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection
59. Induction of circulating IL-1 receptor antagonist by IFN treatment
60. Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist
61. Gamma interferon enhances endothelial cell activation induced by tumor necrosis factor but not by interleukin 1
62. Recombinant tumor necrosis factor and immune interferon act singly and in combination tO reorganize human vasculature endothelial cell monolayers
63. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activator
64. Detection of an unusually stable fibrinolytic inhibitor produced by bovine, endothelial cells
65. Urokinase expression in mononuclear phagocytes: Cytokine-specific modulation by interferon-γ and tumor necrosis factor-α
66. Interferon is an inducer of plasminogen activator type I in human orbital fibroblasts
67. Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators
68. Alpha- and gamma interferon inhibit plasminogen activator inhibitor-1 gene expression in human retinal pigment epithelial cells
69. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon
70. Interferon counteracts interleukin-1α stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro
71. Effect of interferon alpha, interferon gamma and tumor necrosis factor on the procoagulant activity of human cancer cells
72. Fibrinolytic response to interferon-α in healthy human subjects
73. Plasminogen activator inhibitor-1 and atherothrombosis
74. Impaired fibrinolysis in cyclosporintreated renal transplant patients
75. Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis
76. Thyroid autoimmunity in patients on long-term therapy with leukocyte-derived interferon
77. An autoimmune aetiology for hypothyroidism following interferon treatment for breast cancer
78. Induction of hyperthyroidism by interferon-alpha
79. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
80. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis
81. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C
82. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis
83. Thyroiditis after treatment with interleukin-2 and interferon-α2a
84. Suppression of HLA class II expression on thyrocytes by interferon-alpha 1
85. Cytokines as modulators of thyroid functions
86. 125I-organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, and interferon gamma in human thyrocytes in suspension culture
87. Interleukin-6 inhibits human thyroid peroxidase expression
88. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans
89. Tumor necrosis factor: A putat ve mediator of the sick euthyroid syndrome in man
90. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal-axis in humans
91. Elevated interleukin-6 and γ-globulin during interferon therapy of hepatitis B
92. 3 in nonthyroidal illness
93. Effect of interleukin-6 on hypothalamic-pituitary-axis in rat
94. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (hep G2) cells
95. Biology of disease. Interleukin-6: A multifunctional cytokine regulating immune reactions and the acute phase response
96. Metabolic response to infection
97. Metabolic response to sepsis and trauma
98. Hormonal control of metabolism in trauma and sepsis
99. The metabolic response to trauma and sepsis
100. Synergistic interactions among anti-insulin hormones in the pathogenesis of stress hyperglycemia in humans
101. Role of counterregulatory hormones in the catabolic response to stress
102. Combined hormonal infusion simulates the metabolic response to injury
103. Cytokines: Role in human metabolism
104. Endocrine and metabolic effects of interferon-α in humans
105. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
106. Endocrine and metabolic effects of interleukin-6 in humans
107. Central administration of interferon-α enhances rat sympathetic nerve activity to the spleen
108. Cortisol stimulation by recombinant interferon-α2
109. Effects of cloned interferon alpha two in normal volunteers: Febrile reactions and changes in circulating corticosteroids and trace metal
110. Effect of interferon on glucose tolerance and insulin sensitivity
111. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis
112. Decreased glucose oxidation during short-term starvation
113. Effects of interferon alpha on insulin binding and glucose transport in human adipocytes